Important: Therapy
Oral Co-amoxiclav
Notes:
IV co-amoxiclav may be used if the oral route is compromised.
New section added to guidance.
Duration: 5 days
Recommendations on antibiotic choices added, with oral therapy first line except in severe infection.
Coliforms, Staphylococcus aureus, Pseudomonas spp (rare)
Review previous microbiology results prior to prescribing. Tailored antibiotic regime may be required.
5 days
If slow response, treatment can be extended up to a total of 10 days.
Review IV therapy after 24- 48 hours.
Seek advice from paediatric infectious diseases consultant or microbiology if no improvement after 48 hours.
Oral Co-amoxiclav
IV co-amoxiclav may be used if the oral route is compromised.
Oral Clarithromycin
IV clarithromycin may be used if the oral route is compromised.
IV Ceftriaxone* or IV Cefotaxime
* Contraindications to ceftriaxone:
If ceftriaxone is contra-indicated give IV Cefotaxime.
In the absence of microbiology results use Co-amoxiclav for oral switch.
Non-anaphylactic reaction to penicillin:
IV Ceftriaxone* or IV Cefotaxime
* Contraindications to ceftriaxone:
Notes: If ceftriaxone is contra-indicated give IV Cefotaxime.
For oral switch, seek advice from paediatric infectious diseases consultant or microbiology.
Anaphylactic reaction to penicillin:
IV Ciprofloxacin#
+ IV Teicoplanin
# check important safety information in BNFC and provide Medicines for Children: Ciprofloxacin information for parents and carers.
For oral switch, seek advice from paediatric infectious diseases consultant or microbiology.
If less than 5 days since admission to hospital and no additional risk factors (e.g. immunosuppression, neurodisability, home non-invasive ventilation (NIV), recent influenza infection, recent broad spectrum antibiotic use or frequent healthcare contact) then treat as Community-acquired pneumonia.
Assessment of severity should be based on clinical judgement. Markers of severity include:
If features of sepsis, for urgent senior input.
*Parameters for significant tachycardia / tachypnoea:
Age < 12 months: RR > 70, HR > 170,
Age 1 year to < 3 years: RR > 50, HR > 150,
Age 3-5 years: RR >50, HR > 140,
Age 5 to 14 years: RR > 40, HR > 120,
Age 14-17 years: RR >30, HR > 100